Disclaimer: This is an early beta prototype. If you find any error, with data or functionality, please let us know via this page.

Conditions

Interventions

Lay summary

(1) The primary objective is to use descriptive statistics to evaluate the safety of intravenous (IV) and/or oral 6- or 10-day tedizolid phosphate with 10- or 14-day IV and/or oral comparator in subjects 3 months to <12 years of age with acute bacterial skin and skin structure infections (ABSSSI). No formal hypothesis tests will be used to evaluate this endpoint.

Documents

 

Publications

We have no "publications" for this trial. Help us by contributing data.

Registries